Manchester Capital Management LLC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$1,747
-23.4%
1420.0%0.00%
Q2 2023$2,282
-22.0%
142
-15.5%
0.00%
Q1 2023$2,925
+5.9%
168
-43.8%
0.00%
Q4 2022$2,763
-30.9%
299
-32.4%
0.00%
-100.0%
Q3 2022$4,000
-20.0%
442
-32.4%
0.00%0.0%
Q2 2022$5,000
-68.8%
654
+37.4%
0.00%
-50.0%
Q4 2021$16,000
-30.4%
4760.0%0.00%
-33.3%
Q3 2021$23,000
+1050.0%
476
+934.8%
0.00%
Q2 2021$2,000460.00%
Other shareholders
NEOGENOMICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Kopp Family Office, LLC 2,023,355$91,395,00037.83%
Blue Water Life Science Advisors, LP 702,222$31,719,00011.94%
Burrage Capital Management LLC 147,921$6,682,0006.70%
PERKINS CAPITAL MANAGEMENT INC 158,300$7,150,0004.06%
First Light Asset Management, LLC 1,148,945$51,898,0003.11%
Soleus Capital Management, L.P. 352,007$15,900,0002.44%
Ranger Investment Management 832,286$37,594,0001.96%
Avidity Partners Management LP 1,367,000$61,747,0001.67%
Bullseye Asset Management LLC 108,672$4,909,0001.65%
Tygh Capital Management, Inc. 255,541$11,543,0001.57%
View complete list of NEOGENOMICS INC shareholders